TrademarkOpen
Search / United States / 97619994

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

NORMUNITY

Allowed — statement of use stage
Su - Non-Final Action - Mailed
Used for: Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and…
Show more

Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and immune-oncological diseases and other related diseases in the fields of oncology, autoimmune, and immune-oncology

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 8 Oct 2022
    Application filed
    New Application Entered
  2. 30 Nov 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 28 Feb 2023
    Response to office action filed
    Teas Response To Office Action Received
  4. 3 Apr 2023
    Final refusal issued
    Final Refusal Mailed
  5. 5 Jun 2023
    Approved for publication
    Approved For Pub - Principal Register
  6. 11 Jul 2023
    Published for opposition
    Published For Opposition
  7. 5 Sep 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 4 Mar 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 4 Sep 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 26 Feb 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  11. 4 Mar 2026
    Statement of use filed
    Teas Statement Of Use Received
  12. 27 Jul 2026
    Assigned to an examining attorney
    Assigned To Examiner
  13. 24 Aug 2026
    Office action issued
    Non-Final Action Written
All 53 events
2026-08-25Notification Of Non-Final Action E-Mailed
2026-08-24Non-Final Action Written
2026-08-24Non-Final Action E-Mailed
2026-07-27Assigned To Examiner
2026-06-12Case Assigned To Intent To Use Paralegal
2026-06-12Statement Of Use Processing Complete
2026-03-04Teas Statement Of Use Received
2026-03-04Use Amendment Filed
2025-09-15Notice Of Approval Of Extension Request E-Mailed
2025-08-28Sou Teas Extension Received
2025-08-28Sou Extension 4 Filed
2025-08-28Sou Extension 4 Granted
2025-02-27Notice Of Approval Of Extension Request E-Mailed
2025-02-26Sou Teas Extension Received
2025-02-26Sou Extension 3 Filed
2025-02-26Sou Extension 3 Granted
2024-10-31Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-10-31Attorney/Dom.rep.revoked And/Or Appointed
2024-10-31Teas Change Of Correspondence Received
2024-09-04Sou Teas Extension Received
2024-09-04Sou Extension 2 Filed
2024-09-04Sou Extension 2 Granted
2024-09-04Notice Of Approval Of Extension Request E-Mailed
2024-08-30Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-08-30Attorney/Dom.rep.revoked And/Or Appointed
2024-08-30Teas Change Of Correspondence Received
2024-08-30Teas Withdrawal Of Attorney Received-Firm Retains
2024-03-05Notice Of Approval Of Extension Request E-Mailed
2024-03-04Sou Teas Extension Received
2024-03-04Sou Extension 1 Filed
2024-03-04Sou Extension 1 Granted
2023-09-05Noa Mailed - Sou Required From Applicant
2023-07-11Published For Opposition
2023-07-11Official Gazette Publication Confirmation E-Mailed
2023-06-21Notification Of Notice Of Publication E-Mailed
2023-06-05Examiners Amendment -Written
2023-06-05Examiners Amendment E-Mailed
2023-06-05Notification Of Examiners Amendment E-Mailed
2023-06-05Examiner's Amendment Entered
2023-06-05Approved For Pub - Principal Register
2023-04-03Final Refusal Mailed
2023-04-03Final Refusal E-Mailed
2023-04-03Notification Of Final Refusal Emailed
2023-02-28Teas Response To Office Action Received
2023-02-28Correspondence Received In Law Office
2023-02-28Teas/Email Correspondence Entered
2022-12-08Priority Action Written
2022-12-08Priority Action E-Mailed
2022-12-08Notification Of Priority Action E-Mailed
2022-11-30Assigned To Examiner
2022-10-22Notice Of Design Search Code E-Mailed
2022-10-21New Application Office Supplied Data Entered
2022-10-08New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and immune-oncological diseases and other related diseases in the fields of oncology, autoimmune, and immune-oncology

First use anywhere 0 Oct 2025 · First use in commerce 0 Oct 2025

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 25 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.